Assessment of Fluid Responsiveness in Septic Shock Patients, Can End-tidal co2 Measurement Help?

January 23, 2023 updated by: hüseyin özkarakaş, Bozyaka Training and Research Hospital

Assessment of Fluid Responsiveness in Septic Shock Patients, Can End-tidal co2 Measurement Help?, a Prospective Observational Study

Fluid therapy is important in patients with sepsis and septic shock. There are many invasive and non-invasive methods to assess fluid responsiveness in patients. The specificities and sensitivities of these methods are highly variable. The reason for our study was to determine end-tidal co2 and fluid responsiveness in septic shock patients. The aim of the study was to evaluate the fluid response using the End-tidal CO2 difference in septic shock patients receiving intubated mechanical ventilation support.

Study Overview

Detailed Description

End-tidal CO2 is a parameter that can be easily measured with our non-invasively available monitors. If results are positive, fluid response of patients can be measured with a non-invasive, easy-to-apply method.

The significance of end-tidal CO2 will be confirmed by the passive leg raise test. Assessment of fluid responsiveness with the passive leg raise test is currently seen as the non-invasive reference test used.

It has proven its accuracy and reliability in many studies. In the passive leg raise test, end-tidal CO2 will be compared between the group with and without fluid responsiveness.

Scope of the study: Patients hospitalized in the general and reanimation intensive care units of our hospital and diagnosed with septic shock for any reason.

Method(s) to be applied: All patients diagnosed with septic shock will be included in the study.

The passive leg raise test, will be applied to the patients, and cardiac output and end-tidal CO2 changes will be recorded with transthoracic echocardiography before and after.

Fluid responsiveness is considered to be present in patients whose stroke volume variation output change measured by echocardiography increases by 10% or more after the passive leg raise test.

Patients will be divided into 2 groups according to fluid responsiveness. Group-1 group with fluid responsiveness in passive leg raise test, Group-2 group with no fluid response in passive leg raise test. End-tidal CO2 will be compared between groups.

Passive leg raise test: After the patients are in a semi-sitting position (at least 2 minutes), two healthcare professionals will take the supine position and then lift their legs 45 degrees, wait for 2 minutes and return to the initial position.

With this maneuver, it is anticipated that approximately 150-300 ml of autotransfusion will be administered to the patient.

Statistical analyzes will be made with the SPSS 21 program. Normally distributed data will be expressed as mean ± standard deviation, non-normally distributed data will be expressed as median. Categorical data will be expressed as a percentage. The difference between the mean and median values will be evaluated according to the distribution of the data by Student's t or Mann-Whitney U test. Categorical data will be evaluated with the chi-square test. A p value <0.05 will be considered significant.

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Karabağlar
      • Izmir, Karabağlar, Turkey, 35100
        • Recruiting
        • UHS Izmir Bozyaka Education and Research Hospital
        • Contact:
          • Mehmet Ugur Bilgin
          • Phone Number: +905545118874

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients hospitalized in the general and reanimation intensive care units of our hospital and diagnosed with septic shock for any reason

Description

Inclusion Criteria:

  • over 18 years old
  • in circulatory shock
  • Hemodynamically stable for 10 minutes (whether or not he takes vasoactive drugs)
  • Followed in mechanical ventilation with invasive arterial monitoring

Exclusion Criteria:

  • pregnant
  • Heart cannot be visualized by echocardiography
  • Patients for whom passive leg raise test cannot be performed
  • Bilateral lower extremity amputation
  • Patients who are hemodynamically unstable

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group-1

group with fluid responsiveness in passive leg raise test After the patients are in a semi-sitting position (at least 2 minutes), two healthcare professionals will take the supine position and then lift their legs 45 degrees, wait for 2 minutes and return to the initial position.

10% change in stroke volume will be considered positive and patients will be divided into 2 groups as fluid-responsive and non-responsive.

(0,1,3,5 minutes measurements will be taken) measured before and after the test will be recorded and compared.

Cardiac output and stroke volume variation, vci distensibility will be measured and recorded by a specialist cardiologist using siemens ocuson cv70 (Siemens AG Medical Solutions, Henkestrasse, the Germany) echocardiography before and after the test.

Group-2

group with no fluid response in passive leg raise test After the patients are in a semi-sitting position (at least 2 minutes), two healthcare professionals will take the supine position and then lift their legs 45 degrees, wait for 2 minutes and return to the initial position.

10% change in stroke volume will be considered positive and patients will be divided into 2 groups as fluid-responsive and non-responsive.

(0,1,3,5 minutes measurements will be taken) measured before and after the test will be recorded and compared.

Cardiac output and stroke volume variation, vci distensibility will be measured and recorded by a specialist cardiologist using siemens ocuson cv70 (Siemens AG Medical Solutions, Henkestrasse, the Germany) echocardiography before and after the test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
end tidal co2
Time Frame: Recording will be made immediately before the passive leg raise test.
the level of carbon dioxide that is released at the end of an exhaled breath
Recording will be made immediately before the passive leg raise test.
end tidal co2
Time Frame: Recording will be made at the 1st minute after the end of the test.
the level of carbon dioxide that is released at the end of an exhaled breath
Recording will be made at the 1st minute after the end of the test.
end tidal co2
Time Frame: Recording will be made 3rd minute after the end of the test.
the level of carbon dioxide that is released at the end of an exhaled breath
Recording will be made 3rd minute after the end of the test.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
diastolic blood pressure
Time Frame: Recording will be made immediately before the passive leg raise test.
Recording will be made immediately before the passive leg raise test.
diastolic blood pressure
Time Frame: Recording will be made at the 1st minute after the end of the test.
Recording will be made at the 1st minute after the end of the test.
diastolic blood pressure
Time Frame: Recording will be made 3rd minute after the end of the test.
Recording will be made 3rd minute after the end of the test.
systolic blood pressure
Time Frame: Recording will be made immediately before the passive leg raise test.
Recording will be made immediately before the passive leg raise test.
systolic blood pressure
Time Frame: Recording will be made at the 1st minute after the end of the test.
Recording will be made at the 1st minute after the end of the test.
systolic blood pressure
Time Frame: Recording will be made 3rd minute after the end of the test.
Recording will be made 3rd minute after the end of the test.
ppv values
Time Frame: Recording will be made immediately before the passive leg raise test.
Pulse pressure variation
Recording will be made immediately before the passive leg raise test.
ppv values
Time Frame: Recording will be made at the 1st minute after the end of the test.
Pulse pressure variation
Recording will be made at the 1st minute after the end of the test.
ppv values
Time Frame: Recording will be made 3rd minute after the end of the test.
Pulse pressure variation
Recording will be made 3rd minute after the end of the test.
vci distensibility
Time Frame: Recording will be made immediately before the passive leg raise test.
Distensibility Index of Inferior Vena Cava
Recording will be made immediately before the passive leg raise test.
vci distensibility
Time Frame: Recording will be made at the 1st minute after the end of the test.
Distensibility Index of Inferior Vena Cava
Recording will be made at the 1st minute after the end of the test.
vci distensibility
Time Frame: Recording will be made 3rd minute after the end of the test.
Distensibility Index of Inferior Vena Cava
Recording will be made 3rd minute after the end of the test.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Zeki T Tekgül, Assoc Prof, Izmir Bozyaka Training and Research Hospital
  • Study Chair: Özkan özmuk, MD, Izmir Bozyaka Training and Research Hospital
  • Study Chair: Çağrı Yeşilnacar, MD, Izmir Bozyaka Training and Research Hospital
  • Study Chair: Oğuz Uçar, MD, Izmir Bozyaka Training and Research Hospital
  • Study Chair: Mehmet Uğur Bilgin, MD, Izmir Bozyaka Training and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 20, 2022

Primary Completion (Anticipated)

February 27, 2023

Study Completion (Anticipated)

March 30, 2023

Study Registration Dates

First Submitted

August 19, 2022

First Submitted That Met QC Criteria

September 27, 2022

First Posted (Actual)

September 28, 2022

Study Record Updates

Last Update Posted (Actual)

January 25, 2023

Last Update Submitted That Met QC Criteria

January 23, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

Subscribe